The pioneering Yellow Card Biobank, launched by the Medicines and Healthcare products Regulatory Agency (MHRA) and Genomics ...

Genomics England’s 2025 Research Summit welcomed a captivated audience to hear about the latest research and technological ...

Greater diversity is needed in genetic research to make genomics’ use in cancer care and screening more accurate and reliable for all, according to a new study. The research, led by Genomics England ...

In this series, we explore some important roles in the life sciences, and how their work impacts patients and families. In this blog, Clinical Bioinformatician Clare Kennedy shares her experience in ...

New research shows almost 90% of people in England would agree to genetic testing to get the most effective medication and reduce the risk of side effects 85% thought that the NHS should offer ...

At Genomics England, we are committed to transforming health outcomes through innovation in genomics that benefit all patients, regardless of their background. Our Diverse Data Initiative is leading ...

In this series, we explore some important roles in the life sciences, and how their work impacts patients and families. In this blog, we spoke to Andreia Rogerio, Applied Machine Learning Engineer, ...

A new study led by Genomics England and Queen Mary University of London estimates that genetic testing could identify approximately 14,540 patients per year on any of 5 commonly prescribed drugs who ...

The Generation Study is a research initiative aiming to explore the use of whole genome sequencing in newborns, to screen for more than 200 rare genetic conditions.This study will recruit 100,000 ...

Hundreds of babies have begun to be tested for over 200 rare genetic conditions as part of a world-leading study in NHS hospitals that aims to screen up to 100,000 newborns in England. The Generation ...